It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma by Christin Knickmeier, Gaetan Aime Noubissi Nzeteu, Bernhard F. Gibbs, Frederik J. H. Hoogwater, Maarten W. Nijkamp, Maximilian Bockhorn, N. Helge Meyer

Get full text

STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma – a single-arm multicentre phase II study by Derk Jan de Groot, Luisa Vonghia, Bas Groot Koerkamp, Lydi M J W van Driel, Alejandra Méndez Romero, Anne Demols, Erik van Werkhoven, Dirk De Ruysscher, Christelle Bouchart, Marjolein Y V Homs, Joris I Erdmann, Martijn Intven, Ferry Eskens, Harm Westdorp, Timon Vandamme, Suus Y van Loosbroek, Maaike T W Milder, Rianne D W Vaes, Wilhelm den Toom, François Willemssen, Yvette Seppenwoolde, Nadia Haj Mohammad, Joep de Bruijne, Eva Versteijne, Anna M Bruynzeel, Freek Brandts, Pètra M Braam, Eric T T L Tjwa, Akos Gulyban, Jeroen Buijsen, Judith de Vos-Geelen, Maxime Dewulf, Ines Joye, Margriet Dieters, Fred J F Ubbels, Frederik J H Hoogwater, Ben Heijmen

Get full text